Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Participants
Clinical trial NCT04520451 · COMPLETED
Trial details
- NCT number
- NCT04520451
- Sponsor
- Principia Biopharma, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-22
- Primary completion
- 2024-10-15
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.